Expert in pre-clinical & clinical analyses
on mitochondrial behavior & product safety
High content phenotypic analysis of the mitochondrial behavior
What these analyses provide:
- Simultaneous study in 4 dimensions
- Ranking of products in development with regard to the potential for toxicity of each
- Reliable prediction of chronic toxic events
- Use of relevant primary human cells for testing
- Study of safety of products using models that offer superior alternatives to animal experimentation
- Anti-viral drugs
- Anti-cancer drugs
- Cardio-metabolic diseases
- CNS diseases
- Muscle dystrophies
![[JPG] 40649569](view.php/40649569.jpg "[JPG] 40649569")
Measurement of drug efficacy:
- CNS degeneration
- Huntington's disease model
- Anti-aging products
